Revolution Medicines, Inc.
RVMD
$36.63
-$0.64-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.03% | -37.52% | -71.14% | -75.27% | -86.87% |
| Total Depreciation and Amortization | 38.37% | 30.64% | 28.24% | 14.87% | -4.09% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 29.42% | -23.42% | 28.13% | 20.15% | 24.32% |
| Change in Net Operating Assets | 766.35% | -98.90% | -1,127.01% | -298.34% | 19.43% |
| Cash from Operations | -31.77% | -59.01% | -84.96% | -109.76% | -93.73% |
| Capital Expenditure | -13.89% | -33.37% | -37.58% | -12.29% | 14.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.71% | -62.48% | -1,460.65% | -169.04% | -995.07% |
| Cash from Investing | 45.78% | -61.82% | -1,865.12% | -160.49% | -826.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,151.92% | 120.11% | -80.02% | -98.28% | -88.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -88.62% | -88.62% | 2,001,885.71% | 2,001,885.71% | 2,001,885.71% |
| Cash from Financing | 5.93% | -21.95% | 109.64% | 23.26% | 44.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 133.30% | -128.43% | -186.97% | -137.83% | -141.72% |